BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38047872)

  • 41. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma.
    Hasegawa S; Yokoi K; Okada M; Tanaka F; Shimokawa M; Daimon T; Nakano T
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1940-1947.e5. PubMed ID: 34419248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. External validation of prognostic indices for overall survival of malignant pleural mesothelioma.
    Kataoka Y; Yamamoto Y; Otsuki T; Kaku S; Maehashi-Wada N; Fukuma S; Hirabayashi M; Nakano T; Fukuhara S
    Lung Cancer; 2017 Nov; 113():88-92. PubMed ID: 29110856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
    Cao C; Tian D; Park J; Allan J; Pataky KA; Yan TD
    Lung Cancer; 2014 Feb; 83(2):240-5. PubMed ID: 24360321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-incisional pleurectomy/decortication for malignant pleural mesothelioma.
    Tanaka F; Takenaka M; Imanishi N; Hirai A; Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Kuroda K
    Gen Thorac Cardiovasc Surg; 2021 Sep; 69(9):1320-1325. PubMed ID: 34028663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.
    Takuwa T; Hashimoto M; Matsumoto S; Kondo N; Kuribayash K; Nakano T; Hasegawa S
    Int J Clin Oncol; 2017 Oct; 22(5):857-864. PubMed ID: 28439676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
    Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
    Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions.
    Larose F; Quigley N; Lacasse Y; Martel S; Lang-Lazdunski L
    Lung Cancer; 2021 Jun; 156():151-156. PubMed ID: 33962765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of malignant pleural mesothelioma with chemotherapy preceding versus after surgical resection.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Friedberg JS; Simone CB
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):758-766.e1. PubMed ID: 30454981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
    Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
    Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
    Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical indications and results after chest wall resection for recurrent mesothelioma.
    Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
    Saddoughi SA; Abdelsattar ZM; Blackmon SH
    Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
    Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
    Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multimodal management of malignant pleural mesothelioma: where are we today?
    Van Schil PE; Opitz I; Weder W; De Laet C; Domen A; Lauwers P; Hendriks JM; Van Meerbeeck JP
    Eur Respir J; 2014 Sep; 44(3):754-64. PubMed ID: 24525443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.